Authors: VANLEEUWEN FE CHORUS AMJ VANDENBELTDUSEBOUT AW HAGENBEEK A NOYON R VANKERKHOFF EHM PINEDO HM SOMERS R

Citation: Fe. Vanleeuwen et al., LEUKEMIA RISK FOLLOWING HODGKINS-DISEASE - RELATION TO CUMULATIVE DOSE OF ALKYLATING-AGENTS, TREATMENT WITH TENIPOSIDE COMBINATIONS, NUMBEROF EPISODES OF CHEMOTHERAPY, AND BONE-MARROW DAMAGE, Journal of clinical oncology, 12(5), 1994, pp. 1063-1073

Authors: VANLEEUWEN FE KLOKMAN WJ HAGENBEEK A NOYON R VANDENBELTDUSEBOUT AW VANKERKHOFF EHM VANHEERDE P SOMERS R

Citation: Fe. Vanleeuwen et al., 2ND CANCER RISK FOLLOWING HODGKINS-DISEASE - A 20-YEAR FOLLOW-UP-STUDY, Journal of clinical oncology, 12(2), 1994, pp. 312-325

Authors: VANLEEUWEN FE STIGGELBOUT AM VANDENBELTDUSEBOUT AW NOYON R ELIEL MR VANKERKHOFF EHM DELEMARRE JFM SOMERS R

Citation: Fe. Vanleeuwen et al., 2ND TUMORS AFTER RADIATION TREATMENT OF TESTICULAR GERM-CELL TUMORS -REPLY, Journal of clinical oncology, 11(11), 1993, pp. 2286-2287